Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KHIGH RiskNegative

Callan JMB Inc.

callanjmb.com
Filed: Jun 29, 2026CIK: 0002032545Health Care
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Callan JMB Inc. received a Nasdaq delisting notice on June 29, 2026, for failing to maintain the minimum $1.00 per share bid price requirement over the last 30 business days. While the notice has no immediate effect on listing status, it signals the company must take corrective action to avoid delisting.

Key Takeaways

Company received formal notice from Nasdaq that it no longer meets minimum bid price requirement of $1.00 per share

Notice is based on closing bid price performance over the last 30 consecutive business days

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJun 29, 2026
Item5.02
CategoryExecutive Change
CIK0002032545
Accession #001-42506
Risk LevelHIGH
SentimentNegative
Signalrisk
Topics
regulatory

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings